On May 14-15th 2018, Bayer hosted a two-day workshop for PREFER consortium members and invited stakeholders on PREFER clinical case studies in Berlin, Germany. On the first day PREFER was presented to a wider audience in an open workshop. The second day mixed elements of plenary discussions and breakout sessions as part of a consortium working meeting to plan for case studies. The event was concluded by a Steering Committee meeting to discuss specific actions.
Isabelle Manneh-Vangramberen was part of the organising committee as the Patient Advisory Group (PAG) Lead. ECPC President Francesco de Lorenzo and Board Member Maude Andersson also attended the workshop. ECPC Secretary Jana Pelouchova attended as representative of the Diagnoza CML patient organisation.